Browse the evidence

Genetically elevated body mass index (BMI) in early adulthood causally increases the risk of developing multiple sclerosis (MS), with a 1 standard deviation increase in BMI associated with a 41% increase in MS odds.

Maintaining a healthy body weight, particularly during childhood and early adulthood, is a critical, modifiable strategy to reduce the risk of developing multiple sclerosis. This study provides strong causal evidence that higher BMI directly increases MS risk, suggesting that weight management interventions are not just for metabolic health but also for neurological protection.

In common obesity, endogenous hyperleptinemia fails to inhibit energy intake or increase energy expenditure, a state termed leptin resistance, which is driven by impaired blood-brain barrier transport and intracellular signaling defects (e.g., SOCS-3) in the arcuate nucleus.

Understand that in common obesity, your body's natural 'off switch' for hunger (leptin) is broken or ignored. This is why willpower alone often fails against high-calorie foods. Treatment strategies must bypass this broken signal (e.g., via medications that act downstream or on different pathways) rather than relying on the body's own leptin.

Insulin resistance promotes the development of Alzheimer's disease pathology through multiple interconnected mechanisms including reduced cerebral glucose metabolism, impaired amyloid-beta clearance via competition for insulin-degrading enzyme (IDE), and increased amylin deposition.

Maintaining metabolic health, specifically insulin sensitivity, is a critical strategy for reducing Alzheimer's risk. This involves managing blood sugar, avoiding excessive refined carbohydrates, and engaging in regular physical activity to improve insulin signaling. For those with existing insulin resistance or type 2 diabetes, aggressive management of these conditions may help protect brain health.

Testosterone treatment in older men with low testosterone increases coronary artery noncalcified plaque volume, but was not associated with more cardiovascular or prostate adverse events over 12 months.

If you are an older man with confirmed low testosterone, testosterone therapy may increase your coronary artery noncalcified plaque volume, but this was not associated with more cardiovascular or prostate adverse events over 12 months. The treatment involves daily application of a gel, with dose adjustments to keep levels in the normal range for young men. Long-term safety requires more data.

Oral contraceptives are the primary medical treatment for regulating menstrual cycles and treating hirsutism in PCOS, but they do not address the underlying insulin resistance and may worsen lipid profiles.

Oral contraceptives are a common and effective way to regulate periods and reduce excess hair growth in PCOS. They work by lowering active testosterone. However, they don't fix insulin resistance and might affect your cholesterol, so your doctor will check your lipids and blood pressure. They are not suitable for everyone, especially smokers over 35.

Melatonin administration significantly reduces sleep-onset latency (SOL) in children with DSPD, but this effect is not statistically significant in adults.

Parents of children with DSPD may observe faster sleep onset with melatonin, whereas adults may not experience this specific benefit despite phase shifting.

Obesity and insulin resistance drive elevated plasma Plasminogen Activator Inhibitor-1 (PAI-1) levels primarily through adipocyte overexpression of PAI-1, mediated by cytokines (TNF-alpha, TGF-beta) and insulin, thereby increasing cardiovascular thrombotic risk.

Excess body fat, particularly visceral fat, actively contributes to heart disease risk by secreting proteins that promote blood clots. This is not just 'storage'; it is an active hormonal process. Losing weight, even moderately, can significantly lower these clot-promoting proteins, reducing cardiovascular risk.

Metformin improves healthspan and reduces early mortality from age-related diseases (cardiovascular disease, cancer, diabetes) but does not directly extend maximum lifespan in humans.

If you have Type 2 Diabetes or are at high risk, metformin is a standard, safe, and effective treatment that significantly reduces your risk of heart disease, cancer, and early death. While it may not make you live to 100, it helps you stay healthy longer by managing blood sugar and protecting your blood vessels. Discuss with your doctor if it is appropriate for you, keeping in mind potential stomach upset which can often be managed.

A low-fat diet decreases HDL cholesterol levels by reducing HDL apolipoprotein A-I transport rates (synthesis/production), not by increasing catabolic rates.

If you switch to a low-fat diet to protect your heart, your HDL ('good') cholesterol numbers will likely drop by about 30%. Do not stop the diet because of this. The paper proves this drop happens because your body makes less HDL, not because it destroys it faster. This is a different, likely less dangerous, mechanism than having naturally low HDL. The benefit of lowering your 'bad' LDL cholesterol far outweighs the concern about the HDL number dropping.

Acute insulin deprivation in type 1 diabetes causes significant perturbations in metabolic pathways, specifically elevating ketones, lactate, branched-chain amino acids, and oxidative stress markers, while simultaneously decreasing mitochondrial ATP production capacity.

In type 1 diabetes, missing or withholding insulin leads to a complex metabolic state involving high blood sugar, ketone production, and muscle breakdown. This is not just about high glucose; it involves significant stress on the body's energy systems and increased oxidative stress. Managing insulin levels is critical to preventing these widespread metabolic disruptions.

Mid-day time-restricted feeding (mTRF), defined as an 8-hour eating window between 11:00 and 20:00, does not significantly improve insulin sensitivity, fasting glucose, body mass, or inflammation compared to ad libitum eating in healthy non-obese adults.

If you prefer eating later in the day (e.g., 11 AM to 7 PM), be aware that this specific mid-day TRF window may not improve insulin sensitivity, reduce body weight, or lower inflammation compared to normal eating habits in healthy, non-obese individuals. If metabolic health is your goal, shifting your eating window to end earlier (by 3 PM) may be more effective.

Hyperinsulinemia in type 2 diabetes increases cancer risk by upregulating IR-A and IGF1R receptors on cancer cells, promoting growth through PI3K/Akt and MAPK pathways.

Type 2 diabetes is linked to higher cancer risk, partly because high insulin levels can stimulate cancer cell growth. Managing blood sugar and insulin resistance is crucial for cancer prevention in diabetic patients.

The direct pathway (glucose -> UDP-glucose -> glycogen) accounts for 46-68% of hepatic glycogen synthesis postprandially, with the proportion increasing in the later stages (4-6 hours) after a meal.

After eating, your liver primarily makes glycogen directly from the glucose in your food (46-68% of the process), rather than from other precursors. This direct route becomes even more dominant in the hours following the meal.

Modulating reactive oxygen species (ROS) levels through antioxidant interventions does not consistently extend lifespan or delay age-related diseases, contradicting the mitochondrial free radical theory of ageing.

Do not rely on antioxidant supplements to extend your lifespan or prevent ageing. Current evidence from genetic models suggests that manipulating ROS levels does not consistently improve longevity and may interfere with natural stress-response mechanisms. Focus on proven interventions like dietary restriction or exercise, which may work by inducing mild, beneficial stress (mitohormesis) rather than simply neutralizing ROS.

Mitochondrial DNA (mtDNA) mutations accumulate with age primarily due to replication errors rather than oxidative damage, and while high levels of mutations can cause premature ageing, normal levels may not be the primary driver of ageing.

Focus on maintaining overall cellular health rather than targeting 'mitochondrial damage' specifically with antioxidants. The accumulation of mtDNA mutations is likely due to replication errors, not just oxidative stress. Strategies that support stem cell function and stress response (like exercise) may be more effective than trying to 'repair' mtDNA directly.

Reactive oxygen species (ROS) function as essential signaling molecules that mediate stress responses and adaptation, rather than solely as damaging agents, a concept known as the 'gradual ROS response hypothesis'.

Understand that some oxidative stress is normal and necessary. Your body uses ROS as signals to adapt to stress, such as exercise or dietary restriction. Do not try to eliminate all ROS with high-dose antioxidants, as this may interfere with these beneficial signaling pathways. Embrace mild stressors that trigger adaptive responses.

Deficiency in the mPer2 clock gene disrupts the diurnal rhythm of hypothalamic alpha-MSH, leading to loss of feeding rhythm, light-period hyperphagia, and obesity on a high-fat diet.

If you struggle with night-time eating or obesity, your internal body clock (specifically the mPer2 gene's regulation of alpha-MSH) might be driving your hunger at the wrong times. This isn't just willpower; it's a hormonal rhythm. Aligning your eating window with your active/dark period (or treating light-period eating as a medical symptom) may help. The paper suggests that restoring the alpha-MSH pulse can reverse this pattern.

Peripheral administration of alpha-MSH restores the feeding rhythm and induces weight loss in mPer2-deficient mice by compensating for the disrupted hypothalamic alpha-MSH pulse.

For individuals with circadian eating disorders like night-eating syndrome, restoring the body's natural alpha-MSH rhythm might be key. This study shows that replacing this hormone can reduce food intake and weight, even on a high-fat diet. This supports the potential for targeted hormonal therapies for circadian-based obesity.

Activation of the AMPKα2 isoform inhibits skeletal muscle hypertrophy and promotes protein degradation (atrophy) by suppressing mTORC1 signaling and activating FoxO-mediated ubiquitin-proteasome pathways.

If your goal is maximum muscle size, be aware that high-intensity endurance exercise or conditions that heavily activate AMPK (like severe caloric restriction) may blunt muscle growth. This is because the body prioritizes energy production over building new tissue. To maximize hypertrophy, focus on resistance training protocols that minimize excessive AMPK activation (e.g., avoid excessive cardio immediately before lifting).

Sleeping more than 9 hours per day is associated with an increased risk of stroke, potentially due to poor sleep quality or underlying comorbidities.

If you consistently sleep more than 9 hours, consider consulting a doctor to rule out underlying issues like sleep apnea or inflammation, as this pattern is linked to a higher risk of stroke.

Obese women with Polycystic Ovary Syndrome (PCOS) have a significantly higher prevalence and severity of Obstructive Sleep Apnea (OSA) compared to age- and weight-matched controls, driven by elevated androgen levels and central obesity.

If you are an obese woman diagnosed with PCOS, you should be screened for Obstructive Sleep Apnea (OSA) even if you do not snore heavily. The risk is significantly higher than in other obese women due to hormonal factors. Ask your doctor for a sleep study if you experience daytime sleepiness or other symptoms.

Disruption of arcuate nucleus (ARC) neuronal regulation of energy balance and glucose homeostasis is a primary driver of obesity and type 2 diabetes mellitus.

Understanding that obesity is driven by biological signals in the brain (specifically the arcuate nucleus) helps explain why willpower alone is often insufficient for weight loss. This biological perspective supports the need for medical or behavioral interventions that address these underlying regulatory mechanisms rather than blaming individual choice.

AgRP neurons promote feeding and induce acute insulin resistance to prioritize glucose availability for the brain during hunger.

During periods of fasting or caloric restriction, the body biologically reduces insulin sensitivity in peripheral tissues to ensure the brain receives enough glucose. This is a survival mechanism driven by AgRP neurons, not a defect.

Leptin signaling in the arcuate nucleus is critical for regulating body weight, with its effects mediated primarily through AgRP and POMC neurons.

Leptin signals fat stores to the brain to regulate hunger. In obesity, this signaling may be disrupted (leptin resistance), making weight management harder. Understanding this biological signal helps explain why simple calorie restriction often fails long-term.